Multiphasic contrast-enhanced MRI: Single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 5, 2013, Pages 1160-1167

  Vargas, Hebert Alberto ^a   Delaney, Holly G ^a   Delappe, Eithne M ^a   Wang, Ya ^a   Zheng, Junting ^a   Moskowitz, Chaya S ^a   Tan, Yongqiang ^b   Zhao, Binsheng ^b   Schwartz, Lawrence H ^b   Hricak, Hedvig ^a   Russo, Paul ^a   Akin, Oguz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

aggressiveness; clear cell carcinoma; genitourinary; magnetic resonance imaging; oncology; renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS POTENTIAL; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ALGORITHMS; CARCINOMA, RENAL CELL; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 84876475370     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23899     Document Type: Article

References (38)

1. Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010; 183: 1309-1316.
2. Teloken PE, Thompson RH, Tickoo SK, et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 2009; 182: 2132-2136.
3. Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA,. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res 2003; 9: 4641-4652.
4. Banumathy G, Cairns P,. Signaling pathways in renal cell carcinoma. Cancer Biol Ther 2010; 10: 658-664.
5. Lam JS, Shvarts O, Said JW, et al. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 2005; 103: 2517-2525.
6. Klatte T, Said JW, de Martino M, et al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol 2009; 181: 1558-1564.
7. Minervini A, Di Cristofano C, Gacci M, et al. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol 2008; 180: 1284-1289.
8. Ficarra V, Martignoni G, Maffei N, et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005; 103: 68-75.
9. Fuhrman SA, Lasky LC, Limas C,. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-663.
10. Lebret T, Poulain JE, Molinie V, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007; 178: 1184-1188.
11. Schmidbauer J, Remzi M, Memarsadeghi M, et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 2008; 53: 1003-1012.
12. Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008; 180: 2333-2337.
13. Ficarra V, Brunelli M, Novara G, et al. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours. Pathology 2011; 43: 149-155.
14. Al Nazer M, Mourad WA,. Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagn Cytopathol 2000; 22: 223-226.
15. Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 2011; 60: 578-584.
16. Pedrosa I, Chou M, Ngo L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol 2008; 18: 365-375.
17. Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J,. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 2010; 195: W344-351.
18. Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 2009; 250: 793-802.
19. Mehta CR, Patel NR,. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc 1983; 78: 427-434.
20. Dunn OJ,. Multiple comparisons among means. J Am Stat Assoc 1961; 56: 52-64.
21. Law M, Young R, Babb J, Pollack E, Johnson G,. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007; 28: 761-766.
22. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009; 181: 2033-2036.
23. Crispen PL, Wong YN, Greenberg RE, Chen DY, Uzzo RG,. Predicting growth of solid renal masses under active surveillance. Urol Oncol 2008; 26: 555-559.
24. Hsu RM, Chan DY, Siegelman SS,. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 2004; 182: 551-557.
25. Delahunt B, Bethwaite PB, Nacey JN,. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007; 39: 459-465.
26. Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 2010; 194: 438-445.
27. Flanigan RC, Polcari AJ, Hugen CM,. Prognostic variables and nomograms for renal cell carcinoma. Int J Urol 2011; 18: 20-31.
28. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P,. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166: 63-67.
29. Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48-51.
30. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20: 4559-4566.
31. Cindolo L, de la Taille A, Messina G, et al. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int 2003; 92: 901-905.
32. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW,. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 2008; 179: 2146-2151; discussion 2151.
33. Delahunt B,. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 2009; 22: S24-S36.
34. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 2007; 31: 957-960.
35. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B,. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006; 30: 1091-1096.
36. Delahunt B, Bethwaite PB, Nacey JN,. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007; 39: 459-465.
37. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L,. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 2003; 127: 593-596.
38. Lang H, Lindner V, de Fromont M, et al. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with > 15-year follow-up. Cancer 2005; 103: 625-629.